SEC Form 4 · accession 0001654954-19-000796
Monopar Therapeutics · MNPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrice Rioux
Other
Period of report
Dec 30, 2018
Accepted (ET)
Jan 25, 2019 · 8:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645469
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF1 | $6.00 | Dec 30, 2018 | A | 20,000 | A | Jan 31, 2019 | Dec 30, 2028 | Common stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Stock options vest and become exercisable according to the following schedule: 1,667 shares vest on January 31, 2019 and the last day of each subsequent month thereafter.